文献速递乳腺MR

导管原位癌:术前乳腺磁共振定量影像特征与治疗后复发相关

Ductal Carcinoma in Situ: Quantitative Preoperative Breast MR Imaging Features Associated with Recurrence after Treatment.
PubMed 文献 · Radiology · 2017-09-14

回顾性匹配分析415例术前接受乳腺动态增强磁共振的导管原位癌患者,其中14例复发、11例找到匹配对照。复发组功能肿瘤体积、病灶峰值信号增强比和平均背景实质强化均显著高于匹配对照,提示术前定量磁共振特征可能与治疗后复发相关。

要点

  • 复发组功能肿瘤体积中位数9.3 cm³,显著高于对照组的1.3 cm³(P=0.01)。
  • 复发组病灶峰值信号增强比中位数1.7,显著高于对照组的1.2(P=0.03)。
  • 复发组平均背景实质强化中位数58.3%,显著高于对照组的41.1%(P=0.02)。

核心结论

  • 新诊断导管原位癌患者术前磁共振的定量病灶和正常乳腺组织特征,似乎与治疗后乳腺癌复发相关。

研究设计与样本

  • 回顾性研究,2004至2014年术前接受动态对比增强磁共振的导管原位癌患者中识别术后6个月以上同侧复发者,按已知影响复发风险的临床、组织病理和治疗特征匹配无复发对照;415例中14例复发,11例找到可识别匹配对照(最终队列11例患者和11例对照)。

关键影像表现/征象

  • 复发组功能肿瘤体积中位数9.3 cm³,匹配对照组为1.3 cm³(P=0.01)。
  • 复发组病灶峰值信号增强比中位数1.7,匹配对照组为1.2(P=0.03)。
  • 复发组平均背景实质强化中位数58.3%,匹配对照组为41.1%(P=0.02)。

临床应用与阅片要点

  • 术前动态对比增强磁共振可定量测量病灶最长径、功能肿瘤体积、峰值强化百分比、峰值信号增强比和廓清分数。
  • 正常乳腺组织特征包括背景实质强化体积和平均背景实质强化,可一并定量评估。

局限性

  • 415例接受术前磁共振的导管原位癌患者中仅14例复发,其中11例找到可识别匹配对照,最终队列为11例患者和11例对照。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To investigate whether specific imaging features on breast magnetic resonance (MR) images are associated with ductal carcinoma in situ (DCIS) recurrence risk after definitive treatment. Materials and Methods Patients with DCIS who underwent preoperative dynamic contrast material-enhanced (DCE) MR imaging between 2004 and 2014 with ipsilateral recurrence more than 6 months after definitive surgical treatment were retrospectively identified. For each patient, a control subject with DCIS that did not recur was identified and matched on the basis of clinical, histopathologic, and treatment features known to affect recurrence risk. On DCE MR images, lesion characteristics (longest diameter, functional tumor volume [FTV], peak percentage enhancement [PE], peak signal enhancement ratio [SER], and washout fraction) and normal tissue features (background parenchymal enhancement [BPE] volume, mean BPE) were quantitatively measured. MR imaging features were compared between patients and control subjects by using the Wilcoxon signed-rank test, with adjustment for multiple comparisons. Results Of 415 subjects with DCIS who underwent preoperative MR imaging, 14 experienced recurrence and 11 had an identifiable matching control subject (final cohort, 11 patients and 11 control subjects). Median time to recurrence was 14 months, and median follow-up for control subjects was 102 months. When compared with matched control subjects, patients with DCIS recurrence exhibited significantly greater FTV (median, 9.3 cm3 vs 1.3 cm3, P = .01), lesion peak SER (median, 1.7 vs 1.2; P = .03), and mean BPE (median, 58.3% vs 41.1%; P = .02). Conclusion Quantitative lesion and normal breast tissue characteristics at preoperative MR imaging in women with newly diagnosed DCIS show promise for association with breast cancer recurrence after treatment. © RSNA, 2017.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Luo J, Johnston BS, Kitsch AE, et al. Ductal Carcinoma in Situ: Quantitative Preoperative Breast MR Imaging Features Associated with Recurrence after Treatment. Radiology. 2017. PMID: 28914599. doi:10.1148/radiol.2017170587

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。